Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer

British Journal of Surgery

Volumn 87, Issue 7, 2000, Pages 920-925

  Jansen, L ^a,d   Doting, M H E ^b   De Vries, J ^c   Valdes Olmos R A ^b   Nieweg, O E ^a  

^a Departments of Surgery   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEU PATENTE V; CYTOKERATIN; DISULFINE BLUE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MAMMARY GLAND; PATHOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TISSUE SECTION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS;

EID: 0033915889     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2168.2000.01437.x     Document Type: Article

References (32)

1. Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 1997; 66: 2-6.
2. Cady B. Case against axillary lymphadenectomy for most patients with infiltrating breast cancer. J Surg Oncol 1997; 66: 7-10.
3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am Surg 1994; 220: 391-8.
4. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 1997; 349:1864-7.
5. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998; 227: 645-51.
6. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
7. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-9.
8. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW et al. Mammary lymphoscintigraphy in breast cancer. J Nud Med 1995; 36: 1775-80.
9. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2: 335-9.
10. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276: 1818-22.
11. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer - a multicenter validation study. N Engl J Med 1998; 339: 941-6.
12. Roumen RMH, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
13. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SD, Rosen PP, Coit DG et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
14. Ringers EJT, Jansen L, Nieweg OE, de Vries J, Schraffordt Koops H, Kroon BBR. Technique of sentinel node biopsy in breast cancer. Eur J Surg Oncol 1998; 24: 316-19.
15. Urban JA, Baker HW. Radical mastectomy in continuity with en bloc resection of the internal mammary lymph-node chain. A new procedure for primary operable cancer of the breast. Cancer 1952; 5: 992-1008.
16. Cody HS III, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol 1995; 2: 32-7.
17. Dixon JM, Dobie V, Chetty U. The importance of interpectoral nodes in breast cancer. Eur J Cancer 1993; 29A: 334-6.
18. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or 'skip' metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 1983; 197: 276-83.
19. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987; 59: 682-7.
20. Hebert-Croteau N, Brisson J, Latreille J, Gariepy G, Blanchette C, Deschenes L. Time trends in systemic adjuvant treatment for node-negative breast cancer. J Clin Oncol 1999; 17: 1458-64.
21. Goldhirsch A, Wood WC, Senn HJ, Click JH, Gelber RD. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1999; 87: 1441-5.
22. Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977; 39: 533-8.
23. Urban JA. Management of operable breast cancer: the surgeon's view. Cancer 1978; 42: 2066-77.
24. Lacour J, Le MG, Hill C, Kramar A, Contesso G, Sarrazin D. Is it useful to remove internal mammary nodes in operable breast cancer? Ear J Surg Oncol 1987; 13: 309-14.
25. Lacour J, LêMG, Caceres E, Koszarowski T, Veronesi U, Hill C. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 1983; 51: 1941-3.
26. Arriagada R, Lê MG, Mouriesse H, Fontaine F, Dewar J, Rochard F et al. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiother Oncol 1988; 11: 213-22.
27. Recht A, Pierce SM, Abner A, Vicini F, Osteen RT, Love SM et al. Regional nodal failure after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol 1991; 9: 988-96.
28. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 1998; 16: 2625-31.
29. Valdagni R, Amichetti M, Ciocca M. Patterns of radiotherapy for early breast cancer in northern Italy compared with European and national standards. Radiother Oncol 1999; 51: 79-85.
30. Vendrell-Torne E, Setoain-Quinquer J, Domenech-Torne FM. Study of normal mammary lymphatic drainage using radioactive isotopes. J Nud Med 1972; 13: 801-5.
31. Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Valdés Olmos RA, Kroon BBR. Reliability of sentinel node biopsy for staging melanoma. Br J Surg 2000; 87: 484-9.
32. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997; 21: 788-92.